MD Anderson study shows key enzyme linked to therapy resistance in deadly lung cancer
University of Texas MD Anderson Cancer CenterResearchers at The University of Texas MD Anderson Cancer Center have identified a link between an enzyme tied to cancer formation and therapy resistance in patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC).